AJP - Lung Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 287: L936-L943, 2004. First published July 9, 2004; doi:10.1152/ajplung.00354.2003
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/L936    most recent
00354.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salinas, D. B.
Right arrow Articles by Verkman, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salinas, D. B.
Right arrow Articles by Verkman, A. S.

CFTR involvement in nasal potential differences in mice and pigs studied using a thiazolidinone CFTR inhibitor

Danieli B. Salinas,1,2 Nicoletta Pedemonte,1 Chatchai Muanprasat,1 Walter F. Finkbeiner,3 Dennis W. Nielson,2 and A. S. Verkman1

1Departments of Medicine and Physiology, Cardiovascular Research Institute, and Departments of 2Pediatrics and 3Pathology, University of California, San Francisco, California 94143

Submitted 6 October 2003 ; accepted in final form 26 June 2004

Nasal potential difference (PD) measurements have been used to demonstrate defective CFTR function in cystic fibrosis (CF) and to evaluate potential CF therapies. We used the selective thiazolidinone CFTR inhibitor CFTRinh-172 to define the involvement of CFTR in nasal PD changes in mice and pigs. In normal mice infused intranasally with a physiological saline solution containing amiloride, nasal PD was –4.7 ± 0.7 mV, hyperpolarizing by 15 ± 1 mV after a low-Cl solution, and a further 3.9 ± 0.5 mV after forskolin. CFTRinh-172 produced 1.1 ± 0.9- and 4.3 ± 0.7-mV depolarizations when added after low Cl and forskolin, respectively. Systemically administered CFTRinh-172 reduced the forskolin-induced hyperpolarization from 4.7 ± 0.4 to 0.9 ± 0.1 mV but did not reduce the low Cl-induced hyperpolarization. Nasal PD was –12 ± 1 mV in CF mice after amiloride, changing by <0.5 mV after low Cl or forskolin. In pigs, nasal PD was –14 ± 3 mV after amiloride, hyperpolarizing by 13 ± 2 mV after low Cl and a further 9 ± 1 mV after forskolin. CFTRinh-172 and glibenclamide did not affect nasal PD in pigs. Our results suggest that cAMP-dependent nasal PDs in mice primarily involve CFTR-mediated Cl conductance, whereas cAMP-independent PDs are produced by a different, but CFTR-dependent, Cl channel. In pigs, CFTR may not be responsible for Cl channel-dependent nasal PDs. These results have important implications for interpreting nasal PDs in terms of CFTR function in animal models of CFTR activation and inhibition.

cystic fibrosis; cystic fibrosis transmembrane conductance regulator; nasal potential difference; chloride channels



Address for reprint requests and other correspondence: A. S. Verkman, 1246 Health Sciences East Tower, Cardiovascular Research Institute, Univ. of California, San Francisco, CA 94143-0521 (E-mail: verkman{at}itsa.ucsf.edu)




This article has been cited by other articles:


Home page
FASEB J.Home page
E. Cormet-Boyaka, J. S. Hong, B. K. Berdiev, J. A. Fortenberry, J. Rennolds, J. P. Clancy, D. J. Benos, P. N. Boyaka, and E. J. Sorscher
A truncated CFTR protein rescues endogenous {Delta}F508-CFTR and corrects chloride transport in mice
FASEB J, November 1, 2009; 23(11): 3743 - 3751.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. D. MacDonald, K. R. McKenzie, M. J. Henderson, C. E. Hawkins, N. Vij, and P. L. Zeitlin
Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L933 - L940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. S. Rogers, W. M. Abraham, K. A. Brogden, J. F. Engelhardt, J. T. Fisher, P. B. McCray Jr., G. McLennan, D. K. Meyerholz, E. Namati, L. S. Ostedgaard, et al.
The porcine lung as a potential model for cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L240 - L263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. S. Verkman
From the farm to the lab: the pig as a new model of cystic fibrosis lung disease
Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L238 - L239.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Routaboul, C. Norez, P. Melin, M.-C. Molina, B. Boucherle, F. Bossard, S. Noel, R. Robert, C. Gauthier, F. Becq, et al.
Discovery of {alpha}-Aminoazaheterocycle-Methylglyoxal Adducts as a New Class of High-Affinity Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1023 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. Liu, M. Luo, L. Zhang, W. Ding, Z. Yan, and J. F. Engelhardt
Bioelectric Properties of Chloride Channels in Human, Pig, Ferret, and Mouse Airway Epithelia
Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Akiba, M. Jung, S. Ouk, and J. D. Kaunitz
A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats
Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G753 - G759.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.